Evotec (ETR:EVT) Shares Down 1.7% - Here's Why

Key Points

• Evotec SE's share price dropped 1.7%, closing at €6.78 ($7.88) after reaching a low of €6.74 ($7.83).
• The trading volume fell drastically to 435,048 shares, which is a 68% decrease from its average session volume of 1,360,000 shares.
• Evotec has a market capitalization of $1.26 billion and operates as a drug discovery and development partner in various therapeutic areas.

Evotec SE (ETR:EVT - )'s share price fell 1.7% during trading on Wednesday . The stock traded as low as €6.74 ($7.83) and last traded at €6.78 ($7.88). 435,048 shares were traded during mid-day trading, a decline of 68% from the average session volume of 1,360,000 shares. The stock had previously closed at €6.90 ($8.02).

Evotec Trading Down 1.7%

The firm's fifty day moving average price is €6.28 and its two-hundred day moving average price is €6.65. The stock has a market capitalization of $1.26 billion, a PE ratio of -7.33, a price-to-earnings-growth ratio of 0.98 and a beta of 1.05.

Evotec Company Profile

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibrosis, immunology, infectious diseases, kidney diseases, liver diseases, pain and inflammation, rare diseases, respiratory diseases, tuberculosis, and women's health.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.